Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 5/20 | 0.54 |
| ▸ | AKR1C2 | P52895 | 5/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | CDC42 | P60953 | 1/20 | 0.54 |
| ▸ | RAC1 | P63000 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.54 |
| ▸ | SNCA | P37840 | 5/20 | 0.52 |
| ▸ | APP | P05067 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Protizinic Acid SCHEMBL25022 | 1.00 | AKR1C3 (0.54) | AKR1C3AKR1C2PTGS2PTGS1TSHR | |
| Protizinic Acid SCHEMBL18309842 | 1.00 | AKR1C3 (0.54) | AKR1C3AKR1C2PTGS2PTGS1TSHR | |
| Protizinic Acid SCHEMBL8208239 | 0.89 | AKR1C3 (0.44) | AKR1C3AKR1C2PTGS2PTGS1TSHR | |
| SCHEMBL2739325 | 0.85 | SNCA (0.59) | PTGS1CYP1A2SNCATP53KDM4E | |
| SCHEMBL10618628 | 0.82 | NOX1 (0.58) | AKR1C3AKR1C2PTGS2PTGS1TSHR | |
| SCHEMBL11255517 | 0.82 | SNCA (0.53) | PTGS1CYP1A2SNCATP53KDM4E | |
| Protizinic Acid SCHEMBL2072946 | 0.80 | PTGS1 (0.63) | AKR1C3AKR1C2PTGS2PTGS1TSHR | |
| SCHEMBL7389154 | 0.77 | SNCA (0.81) | SNCATP53KDM4EMAPK1MAPT | |
| SCHEMBL10941736 | 0.76 | TP53 (0.39) | PTGS2TSHRSNCATP53KDM4E | |
| SCHEMBL2760350 | 0.75 | SNCA (0.64) | SNCATP53KDM4EMAPK1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023023702-A1 | MEDICATED SUPPLEMENT FOR ANIMALS | Medical Ethics Pty Ltd (AU) | 2023-03-02 | — | — | WO | claimed |
| EP-3723819-B1 | WOUND DRESSING | ANIMAL ETHICS PTY LTD (AU) | 2026-04-22 | — | — | EP | disclosed |
| US-20260090869-A1 | SYSTEMS AND DEVICES FOR THE DELIVERY OF TAILORABLE MEDICAMENT TO THE GINGIVAL CREVICE AND METHODS THEREOF | 3I BIOTECH LLC (US) | 2026-04-02 | — | — | US | disclosed |
| US-20250268856-A1 | Pain Relieving Method | ANIMAL ETHICS PTY LTD (AU) | 2025-08-28 | — | — | US | disclosed |
| EP-3976018-B1 | COMPOSITION FOR USE IN THE TREATMENT OF FOOT AND MOUTH DISEASE (FMD), SCABBY MOUTH (ORF), PICORNAVIRUS, PARAPOXVIRUS, AND A PATHOGENIC DISEASE CAUSING POX LESIONS | ANIMAL ETHICS PTY LTD (AU) | 2024-08-28 | — | — | EP | disclosed |
| US-20240091150-A1 | PHARMACEUTICAL COMPOSITION COMPRISING, AS THICKENING AGENT, A COMPOSITION HAVING POLAR MEDIA THICKENING PROPERTIES | SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2024-03-21 | — | — | US | disclosed |
| US-20240024486-A1 | PHARMACEUTICAL COMPOSITION FOR TOPICAL USE COMPRISING A POLYMER IN THE FORM OF A PULVERULENT SOLID AS THICKENING AGENT | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2024-01-25 | — | — | US | disclosed |
| CN-117064886-A | Method for reversing normal aging process and prolonging life | 麦姆德制药公司 | 2023-11-17 | — | — | CN | disclosed |
| EP-4274549-A1 | PHARMACEUTICAL COMPOSITION COMPRISING, AS THICKENING AGENT, A COMPOSITION HAVING POLAR MEDIA THICKENING PROPERTIES | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2023-11-15 | — | — | EP | disclosed |
| EP-4259092-A1 | PHARMACEUTICAL COMPOSITION FOR TOPICAL USE COMPRISING A POLYMER IN THE FORM OF A PULVERULENT SOLID AS THICKENING AGENT | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2023-10-18 | — | — | EP | disclosed |
| US-20220211620-A1 | Pain Relieving Spray | ANIMAL ETHICS PTY LTD (AU) | 2022-07-07 | — | — | US | disclosed |
| WO-2022128453-A1 | PHARMACEUTICAL COMPOSITION FOR TOPICAL USE COMPRISING A POLYMER IN THE FORM OF A PULVERULENT SOLID AS THICKENING AGENT | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2022-06-23 | — | — | WO | disclosed |
| US-20220193037-A1 | PHARMACEUTICAL COMPOSITION FOR TOPICAL USE COMPRISING AT LEAST ONE AZOLATED LOCAL ANTIFUNGAL SUBSTANCE | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2022-06-23 | — | — | US | disclosed |
| US-11338055-B2 | Wound dressing | ANIMAL ETHICS PTY LTD | 2022-05-24 | — | — | US | disclosed |
| EP-3982973-A1 | PAIN RELIEVING METHOD | Animal Ethics Pty Ltd (AU) | 2022-04-20 | — | — | EP | disclosed |
| EP-3976018-A1 | METHOD OF DISEASE CONTROL | Animal Ethics Pty Ltd (AU) | 2022-04-06 | — | — | EP | disclosed |
| EP-3976011-A1 | PAIN RELIEVING SPRAY | Animal Ethics Pty Ltd (AU) | 2022-04-06 | — | — | EP | disclosed |
| CN-114040756-A | Disease control method | 动物伦理私人有限公司 | 2022-02-11 | — | — | CN | disclosed |
| US-20220031707-A1 | PHARMACEUTICAL COMPOSITION FOR TOPICAL USE COMPRISING AT LEAST ONE LOCAL ANAESTHETIC SUBSTANCE | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2022-02-03 | — | — | US | disclosed |
| US-20220023208-A1 | PHARMACEUTICAL COMPOSITION FOR TOPICAL USE COMPRISING AT LEAST ONE ANTIINFLAMMATORY SUBSTANCE | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2022-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220031707-A1 | PHARMACEUTICAL COMPOSITION FOR TOPICAL USE COMPRISING AT LEAST ONE LOCAL ANAESTHETIC SUBSTANCE | MGLL, FAAH, SGPL1 | AKR1C3 482/4885AKR1C2 424/4885PTGS2 303/4885 |
| US-20260090869-A1 | SYSTEMS AND DEVICES FOR THE DELIVERY OF TAILORABLE MEDICAMENT TO THE GINGIVAL CREVICE AND METHODS THEREOF | MALT1, CDH1, VEGFA | AKR1C3 983/4885AKR1C2 776/4885PTGS2 2090/4885 |
| US-20220023208-A1 | PHARMACEUTICAL COMPOSITION FOR TOPICAL USE COMPRISING AT LEAST ONE ANTIINFLAMMATORY SUBSTANCE | CCL11, MGLL, LIPA | AKR1C3 515/4885AKR1C2 578/4885PTGS2 70/4885 |
| US-20240024486-A1 | PHARMACEUTICAL COMPOSITION FOR TOPICAL USE COMPRISING A POLYMER IN THE FORM OF A PULVERULENT SOLID AS THICKENING AGENT | PGA5, SGTA, GYPA | AKR1C3 1841/4885AKR1C2 2275/4885PTGS2 682/4885 |
| US-20240091150-A1 | PHARMACEUTICAL COMPOSITION COMPRISING, AS THICKENING AGENT, A COMPOSITION HAVING POLAR MEDIA THICKENING PROPERTIES | PHOSPHO1, GYPA, SGTA | AKR1C3 4694/4885AKR1C2 4490/4885PTGS2 1371/4885 |
| US-20220193037-A1 | PHARMACEUTICAL COMPOSITION FOR TOPICAL USE COMPRISING AT LEAST ONE AZOLATED LOCAL ANTIFUNGAL SUBSTANCE | ERG28, UGCG, DEGS1 | AKR1C3 51/4885AKR1C2 93/4885PTGS2 1151/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.